Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
drugs
3
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
amgen
biotech
boston blog main
boston top stories
fda
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acadia pharmaceuticals
adverum biotechnologies
aimmune
akcea therapeutics
alder biopharmaceutical
alk
allergan
alnylam pharmaceuticals
american academy of neurology
atogepant
avalon ventures
aveo oncology
barry greene
biogen
biohaven
What
decades
3
×
drug
fda
advanced
ago
alnylam
approval
approve
arguments
arrival
awaits
award
big
bio
biological
cancer
class
commercialized
companies
competitors
crossed
data
death
decision
dems
discovered
drugs
fingers
friday
given
historic
immunotherapy
longer
lung
make
medical
medicine
meeting
migraine
neuro
Language
unset
Current search:
decades
×
drugs
×
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision